Delivery Order SPE2DB22D2211-SPE2DB25FSFXT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a contract ceiling value of $2,707.52. The delivery order is structured as a firm fixed price contract with a completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $10,153.20 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with a firm fixed price structure and an ultimate completion date of September 4, 2025. This contract is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The award was made competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,707.52 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. The contract, which is a child order under a larger vehicle, carries a firm fixed price structure with no set-aside designation and was competitively awarded. The ultimate completion date is June 3, 2025, with performance to be fulfilled at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,107.24 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 22, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.56 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order...
- The Defense Logistics Agency awarded a $1,353.76 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts under a firm fixed-price contract. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation, and performance will be completed at the...
- The Defense Logistics Agency awarded a delivery order valued at $4,061.28 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order as part of its extensive federal medical procurement portfolio serving...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFXTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,997.70 on September 25, 2025, for the supply of Cervidil 10 mg vaginal inserts. This competitive, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement valued through December 2026. That foundational IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, medical supplies, and specialty pharmaceuticals to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, consistently fulfills federal medical procurement requirements across therapeutic domains and demonstrates significant capability to manage both small-value transactions and substantial orders through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/25/25 |